世界の水胞性口内炎（VS）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Vesicular Stomatitis (VS) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5910 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、水胞性口内炎（VS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（症候性薬、予防接種）、用途別市場規模（獣医病院、獣医クリニック、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・水胞性口内炎（VS）治療薬の市場動向 ・企業の競争状況、市場シェア ・水胞性口内炎（VS）治療薬の種類別市場規模（症候性薬、予防接種） ・水胞性口内炎（VS）治療薬の用途別市場規模（獣医病院、獣医クリニック、小売薬局） ・水胞性口内炎（VS）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・水胞性口内炎（VS）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・水胞性口内炎（VS）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・水胞性口内炎（VS）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・水胞性口内炎（VS）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boehringer Ingelheim、Merck & Co、Zoetis、Vedco、Elanco、Ceva Santé Animale、Vibrac、Vetoquinol、IDEXX Laboratories、Covetrus、Neogen） ・結論

Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.

Market Analysis and Insights: Global Vesicular Stomatitis (VS) Therapeutics Market
The global Vesicular Stomatitis (VS) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vesicular Stomatitis (VS) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vesicular Stomatitis (VS) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vesicular Stomatitis (VS) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vesicular Stomatitis (VS) Therapeutics market.

Global Vesicular Stomatitis (VS) Therapeutics Scope and Market Size
Vesicular Stomatitis (VS) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vesicular Stomatitis (VS) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Symptomatic Medications
Vaccination

Segment by Application
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim
Merck & Co
Zoetis
Vedco
Elanco
Ceva Santé Animale
Vibrac
Vetoquinol
IDEXX Laboratories

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Symptomatic Medications
1.2.3 Vaccination
1.3 Market by Application
1.3.1 Global Vesicular Stomatitis (VS) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Perspective (2016-2027)
2.2 Vesicular Stomatitis (VS) Therapeutics Growth Trends by Regions
2.2.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vesicular Stomatitis (VS) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Vesicular Stomatitis (VS) Therapeutics Industry Dynamic
2.3.1 Vesicular Stomatitis (VS) Therapeutics Market Trends
2.3.2 Vesicular Stomatitis (VS) Therapeutics Market Drivers
2.3.3 Vesicular Stomatitis (VS) Therapeutics Market Challenges
2.3.4 Vesicular Stomatitis (VS) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vesicular Stomatitis (VS) Therapeutics Players by Revenue
3.1.1 Global Top Vesicular Stomatitis (VS) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vesicular Stomatitis (VS) Therapeutics Revenue
3.4 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio
3.4.1 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vesicular Stomatitis (VS) Therapeutics Revenue in 2020
3.5 Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Area Served
3.6 Key Players Vesicular Stomatitis (VS) Therapeutics Product Solution and Service
3.7 Date of Enter into Vesicular Stomatitis (VS) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Type
4.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Application
5.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size (2016-2027)
6.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type
6.2.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2027)
6.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application
6.3.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2027)
6.4 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country
6.4.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size (2016-2027)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type
7.2.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application
7.3.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country
7.4.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size (2016-2027)
9.2 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type
9.2.1 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application
9.3.1 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country
9.4.1 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Introduction
11.2.4 Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Introduction
11.3.4 Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.3.5 Zoetis Recent Development
11.4 Vedco
11.4.1 Vedco Company Details
11.4.2 Vedco Business Overview
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Introduction
11.4.4 Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.4.5 Vedco Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Elanco Business Overview
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Introduction
11.5.4 Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.5.5 Elanco Recent Development
11.6 Ceva Santé Animale
11.6.1 Ceva Santé Animale Company Details
11.6.2 Ceva Santé Animale Business Overview
11.6.3 Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Introduction
11.6.4 Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.6.5 Ceva Santé Animale Recent Development
11.7 Vibrac
11.7.1 Vibrac Company Details
11.7.2 Vibrac Business Overview
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Introduction
11.7.4 Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.7.5 Vibrac Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Introduction
11.8.4 Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.8.5 Vetoquinol Recent Development
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Details
11.9.2 IDEXX Laboratories Business Overview
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Introduction
11.9.4 IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.9.5 IDEXX Laboratories Recent Development
11.10 Covetrus
11.10.1 Covetrus Company Details
11.10.2 Covetrus Business Overview
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Introduction
11.10.4 Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.10.5 Covetrus Recent Development
11.11 Neogen
11.11.1 Neogen Company Details
11.11.2 Neogen Business Overview
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Introduction
11.11.4 Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
11.11.5 Neogen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Symptomatic Medications
Table 3. Key Players of Vaccination
Table 4. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Regions (2022-2027)
Table 10. Vesicular Stomatitis (VS) Therapeutics Market Trends
Table 11. Vesicular Stomatitis (VS) Therapeutics Market Drivers
Table 12. Vesicular Stomatitis (VS) Therapeutics Market Challenges
Table 13. Vesicular Stomatitis (VS) Therapeutics Market Restraints
Table 14. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2020)
Table 17. Ranking of Global Top Vesicular Stomatitis (VS) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vesicular Stomatitis (VS) Therapeutics Product Solution and Service
Table 21. Date of Enter into Vesicular Stomatitis (VS) Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Vesicular Stomatitis (VS) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boehringer Ingelheim Company Details
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product
Table 64. Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Merck & Co Company Details
Table 67. Merck & Co Business Overview
Table 68. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product
Table 69. Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Merck & Co Recent Development
Table 71. Zoetis Company Details
Table 72. Zoetis Business Overview
Table 73. Zoetis Vesicular Stomatitis (VS) Therapeutics Product
Table 74. Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Zoetis Recent Development
Table 76. Vedco Company Details
Table 77. Vedco Business Overview
Table 78. Vedco Vesicular Stomatitis (VS) Therapeutics Product
Table 79. Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Vedco Recent Development
Table 81. Elanco Company Details
Table 82. Elanco Business Overview
Table 83. Elanco Vesicular Stomatitis (VS) Therapeutics Product
Table 84. Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Elanco Recent Development
Table 86. Ceva Santé Animale Company Details
Table 87. Ceva Santé Animale Business Overview
Table 88. Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Product
Table 89. Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Ceva Santé Animale Recent Development
Table 91. Vibrac Company Details
Table 92. Vibrac Business Overview
Table 93. Vibrac Vesicular Stomatitis (VS) Therapeutics Product
Table 94. Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Vibrac Recent Development
Table 96. Vetoquinol Company Details
Table 97. Vetoquinol Business Overview
Table 98. Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Vetoquinol Recent Development
Table 100. IDEXX Laboratories Company Details
Table 101. IDEXX Laboratories Business Overview
Table 102. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product
Table 103. IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 104. IDEXX Laboratories Recent Development
Table 105. Covetrus Company Details
Table 106. Covetrus Business Overview
Table 107. Covetrus Vesicular Stomatitis (VS) Therapeutics Product
Table 108. Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Covetrus Recent Development
Table 110. Neogen Company Details
Table 111. Neogen Business Overview
Table 112. Neogen Vesicular Stomatitis (VS) Therapeutics Product
Table 113. Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Neogen Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Symptomatic Medications Features
Figure 3. Vaccination Features
Figure 4. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Veterinary Hospitals Case Studies
Figure 6. Veterinary Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Vesicular Stomatitis (VS) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players in 2020
Figure 14. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue in 2020
Figure 16. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2016-2027)
Figure 38. China Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 58. Merck & Co Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 59. Zoetis Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 60. Vedco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 61. Elanco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 62. Ceva Santé Animale Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 63. Vibrac Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 64. Vetoquinol Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 65. IDEXX Laboratories Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 66. Covetrus Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 67. Neogen Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---